Integrated Wealth Concepts’s TG Therapeutics TGTX Stock Holding History

Integrated Wealth Concepts’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$724K	Buy	+21,800	New	+$650K	0.01%	1301
2025 Q4	–	Sell	-21,960	Closed	-$793K	–	2011
2025 Q3	$793K	Buy	21,960 +15,675	+249%	+$516K	0.01%	1108
2025 Q2	$226K	Buy	+6,285	New	+$234K	﹤0.01%	1701
2021 Q4	–	Sell	-6,398	Closed	-$213K	–	1020
2021 Q3	$213K	Buy	+6,398	New	+$198K	0.01%	874

Other funds holding TGTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Integrated Wealth Concepts's TGTX Position: Q1 2026 in Review

Integrated Wealth Concepts opened a new position in TG Therapeutics (TGTX) in Q1 2026: 21,800 shares worth $724K. The stake represents 0.01% of the portfolio and ranks #1301 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in TGTX as recently as Q3 2025.

Integrated Wealth Concepts first reported a position in TGTX in Q3 2021 and has held it in 4 quarters since. The position peaked at $793K in Q3 2025. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

Integrated Wealth Concepts held 21,800 shares of TG Therapeutics worth $724K as of Q1 2026.
TG Therapeutics was a new Integrated Wealth Concepts position in Q1 2026.
TG Therapeutics made up 0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #1301 holding.
Integrated Wealth Concepts first reported a position in TG Therapeutics in Q3 2021 and has held it in 4 quarters since.
Integrated Wealth Concepts's TG Therapeutics position peaked at $793K in Q3 2025.
363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.